A mathematical model for the effect of Reverse Transcriptase (RT) Inhibitor on the dynamics of HIV is proposed and analyzed. Further, with help of numerical simulations, the relation between efficacy of administered drug, the total number of virus particles emitted from the infected cell and the transition period is also discussed.
Introduction
Mathematical modelling has proved its importance in understanding the dynamics of many biological processes e.g. epidemiology, ecology, virology etc. [1] [2] [3] It has helped to improve our understanding for diseases like HIV. Modelling the level of viremia, when anti-retroviral drugs are administered, has provided insights into the hostpathogenesis interaction of HIV with CD4 + T cells.
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HIV is a retrovirus and its main target is CD4 + T cells. The process of infection completes in the following steps: at the first stage, HIV attaches itself to the CD4 + T cell and then inserts its genetic material, which is in form of RNA, into the host cell. This process is called fusion. Now in the host cell, viral RNA is reverse transcribed into DNA using the protein reverse transcriptase and then this DNA is integrated with host cell genome by integrase. At this moment it is called provirus. When the cell is activated, it starts producing the viral RNA which is then cleaved into proteins using protease to become infectious virus. All these proteins are assembled into a capsid and then viral particles bud out of the cell and mature to infect other CD4 + T cells. 9 The phase of virus life cycle before the production of virus is called as "eclipse phase". 19 ,20 when a virus enters a resting CD4 + T cell, the viral RNA may not be completely reverse transcribed into DNA and the un-integrated virus may decay with time and partial DNA transcripts are labile and degrade quickly. Hence a proportion of infected cells will revert back to uninfected class. In previous models of drug therapy using RT inhibitor, it has been considered that the drug actually affects the interaction-infection rate constant k. 6 These models are based on the assumption that if η be the efficacy of RT inhibitor then the actual infection rate in presence of drug will be (1 − η)k. But it is important to note that reverse transcriptase inhibitor inhibits the reverse transcription which takes place only after the virus has entered the host cell i.e. the process of attachment is over, so drug actually does not directly affect k. To overcome this situation the age structured model was proposed by Rong et al. 21 In view of this we divide the class of infected CD4 + T cells into pre-RT and post-RT class. Now, the RT inhibitor will not allow the reverse transcription and hence the the infected cells in pre-RT class will revert back to uninfected class. But since, drug may not be 100% effective hence only a part of infected cells in pre-RT class will revert back to uninfected class and the remaining will progress to complete reverse transcription and become productively infected and then produce virus.
Model Formulation
We develop a mathematical model for primary infection with RT inhibitor under the above mentioned assumptions. We consider three populations of CD4 + T cells:
(1) T represents density of susceptible CD4 + T cells, (2) T * 1 represents density of infected CD4
+ T cells before reverse transcription (i.e. those infected cells which are in pre-RT class), and (3) T * represents density of infected CD4 + T cells in which reverse transcription is completed (post-RT class) and they are capable of producing virus. V is virus density. After infection, infected cells progress to pre-RT class T * 1 and then they leave pre-RT class at a rate α to productively infected (post-RT) class. These infected cells are capable of producing virus particles. In view of the above discussion, we consider that due to presence of RT inhibitor a fraction of cells ηαT * 1 in pre-RT class reverts back to uninfected class and remaining (1−η)αT * 1 proceeds to post-RT class and become productively infected, where 0 < η < 1 is the efficacy of RT inhibitor. Hence we have the following model:
Here s is the inflow rate of CD4 + T cells and µ its natural death rate. The parameter k is interaction-infection rate of CD4 + T cells (here by infection we mean the attachment and fusion of virus with cell) and µ 1 is death rate of infected cells. α is the transition rate from pre-RT infected CD4 + T cells class to productively infected class (post-RT). b is the reverting rate of infected cells to uninfected class due to non-completion of reverse transcription. 19, 20 The δ represents death rate of actively infected cells and includes the possibility of death by bursting of infected T cells, c is the clearance rate of virus and N is the total number of viral particles produced by an infected cell. The above system has the following two steady states:
The components of E 2 are given as
Feasible existence of E 2 is ensured whenever T > T .
Remark 2.1. From the existence condition for E 2 , i.e. T > T , we may find the critical value for the drug efficacy:
Whenever η < η crit both E 1 and E 2 coexist and when η > η crit , the infection is cleared and only uninfected steady state E 1 will exist.
Boundedness of solution:
Equations (2.1) and (2.2) of the system give
where 
Stability Analysis
In this section we shall establish stability results for steady states E 1 and E 2 .
Proposition 3.1. The non-infected steady state E 1 is locally stable if and only if
Proof. The linearized matrix evaluated at E 1 is given as,
Hence the characteristic equation for M 1 is
where
ks µ . Since one eigenvalue is negative, λ = −µ, the local stability of E 1 demands the negative real parts of all roots of the equation λ 3 + P λ 2 + Qλ + R = 0. Now, it can be easily seen that P Q − R > 0. Hence for Routh-Hurwitz criterion to be satisfied, we need R > 0, which gives
Therefore the non-infected steady state E 1 will be locally asymptotically stable if T < T . Also, for T = T , the characteristic equation has a zero root which is simple and other roots have negative real parts. Hence E 1 will be locally stable when T = T .
Proposition 3.2. The infected steady state E 2 , whenever it exists, is locally asymptotically stable provided the following condition is satisfied:
, and
Proof. The Jacobian matrix evaluated at E 2 is given by
The characteristic equation of M 2 then becomes
Clearly A > 0, D > 0, and ∆ > 0. Therefore using Routh-Hurwitz criterion, all the roots of characteristic equation (3.5) will have negative real part if condition (3.3) is satisfied.
Proposition 3.3. The non-infected steady state E 1 is globally asymptotically stable if T ≤ T .

Proof. Define a Lyapunov function L of system (2.1)-(2.4) as follows:
Its derivative along a solution of system (2.1)-(2.4),
It is clear from ( 
Numerical Simulation
We integrated the system (2. much difference in viral level, though increase in α increases the viral level (see Fig. 2 ). Further, since only small fraction of infected cells will revert back due to incompletion of reverse transcription, 28 we expect the reverting rate b to be small.
We simulated numerically for b = 0 to 0.1 again for same set of parameters as above keeping η = 0.6 and α = 0.4. The results are plotted in Fig. 3 . It can be easily seen that increase in b shows increase in CD4 + T cells and decrease in viral level.
Results and Discussion
In this paper we proposed and analyzed a primary infection model of HIV with CD4 + T cells during therapy. It was considered that only RT inhibitor was given, and accordingly we developed the drug therapy model. The proposed model is different from the existing models in literature and accounts for the events that occur during infection and drug therapy. We subdivided the infected cells class into two subclasses: pre-RT and post-RT. The cells in pre-RT proceed to post-RT with completion of reverse transcription. It is argued that the RT inhibitor will prevent the infected cells in pre-RT class from proceeding to the post-RT class. If the efficacy of drug is not 100% then a fraction of infected cells in pre-RT class will revert back to uninfected class and remaining will proceed to post-RT class. We analyzed the stability of the equilibrium points. If condition (3.1) is satisfied then the infection will be cleared and the non-infected steady state E 1 will be globally stable. It was shown using numerical simulations that for the given set of parameters, when the drug efficacy was 60%, the infected steady state is stable, and when we assume the drug efficacy to be 80%, the level of uninfected cell increases but infection still persists. When the efficacy was increased to 90% the infection was cleared. In literature the value of N varies from 100 to a few thousands.
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We simulated η crit numerically for 0.2 ≤ α ≤ 0.8 and 500 ≤ N ≤ 2500. It can be easily seen from (2.6) that η crit is an increasing function of both N and α (Fig. 4) .
We plotted η crit for N in Fig. 5 (top) and found that larger the value of N , we require higher the efficacy of the drug. Also we plotted η for α and found from graph that increase in α requires high efficacy of drugs (Fig. 5) . 1/α is actually the transition period for CD4 + T cells from pre-RT class to post-RT class. Hence if the transition period is lower we require the efficacy of drug to be higher. Also, it may be noted that for single drug we need it to be highly effective. Therefore for better results of drug therapy we need a combination of therapy. In future we shall work on the effect of combination of drugs. Further, we hope that the model will stimulate experimenters to pose relevant questions that ultimately will help to unravel the nature of the biological mechanism itself.
